Goldman Sachs
ORMP icon

Goldman Sachs’s Oramed Pharmaceuticals ORMP Stock Holding History

Goldman Sachs’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-153,618
Closed -$401K – 5776
2023
Q3 		$401K Buy
153,618
+62,703
+69% +$197K ﹤0.01% 4751
2023
Q2 		$325K Sell
90,915
-10,039
-10% -$32.2K ﹤0.01% 4973
2023
Q1 		$220K Buy
100,954
+84,447
+512% +$268K ﹤0.01% 5258
2022
Q4 		$199K Sell
16,507
-38,395
-70% -$298K ﹤0.01% 5311
2022
Q3 		$355K Buy
54,902
+26,539
+94% +$215K ﹤0.01% 5201
2022
Q2 		$130K Sell
28,363
-41,820
-60% -$223K ﹤0.01% 5783
2022
Q1 		$607K Sell
70,183
-46,851
-40% -$480K ﹤0.01% 5190
2021
Q4 		$1.67M Buy
117,034
+97,266
+492% +$2.03M ﹤0.01% 4404
2021
Q3 		$435K Sell
19,768
-15,287
-44% -$260K ﹤0.01% 5275
2021
Q2 		$469K Buy
35,055
+15,300
+77% +$175K ﹤0.01% 5261
2021
Q1 		$201K Buy
+19,755
New +$162K ﹤0.01% 5647

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $249M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $46.5B AUM 20.93% 1-Year Est. Return